| Justin Parish, | |
|
3406 Glacier Hwy, Juneau, AK 99801-9501 | |
| (907) 463-3303 | |
| Not Available |
| Full Name | Justin Parish |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 3406 Glacier Hwy, Juneau, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023261880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Justin Parish, 3406 Glacier Hwy, Juneau, AK 99801-9501 Ph: (907) 463-3303 | Justin Parish, 3406 Glacier Hwy, Juneau, AK 99801-9501 Ph: (907) 463-3303 |
News Archive
Genencor, a division of Danisco A/S, today introduced Accellerase® DUET at the Renewable Fuels Association's 15th Annual National Ethanol Conference in Orlando, Fla. This product is the latest generation in the company's line of enzymes used to convert biomass into sugars, a critical step in the production of cellulosic ethanol and other advanced biofuels and biochemicals from non-food feedstocks.
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a definitive Clinical Trial Agreement (CTA) with the National Institute on Drug Abuse (NIDA) to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. As part of the CTA, NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the estimated $10 million trial cost.
Researchers at Fudan University in Shanghai, China have developed three different techniques that successfully replace almost all malfunctioning microglia - each technique with its own advantage in application
› Verified 9 days ago
Sanaz Ghorbanpoor, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 | |
Lila A Searer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Leslye Ann Galey, LPC Counselor Medicare: Medicare Enrolled Practice Location: 3260 Hospital Dr, Juneau, AK 99801 Phone: 907-796-8498 | |
Kayli Backes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 | |
Ms. Donna M Zahina, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5594 Aisek St., Juneau, AK 99801 Phone: 907-780-3048 Fax: 907-780-3053 | |
Dany Reyes, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3406 Glacier Hwy, Juneau, AK 99801 Phone: 907-463-3303 Fax: 907-463-6858 |